InsiderClue
← All stocks

GLOBUS MEDICAL INC

GMED Net selling
CIK 0001237831 #875 in the set updated 17 Sep 2026
Bought (120 mo)
$99.82K
out of their own pocket, the only kind of buying there is
Sold (120 mo)
$346.79M
$11.62M on a plan · $317.41M straight out of an exercise
Sold at will
$17.76M
16 of 139 sales
Net
−$346.69M
−$17.66M against sales at will

By person

19 insiders · 149 transactions
Insider
Role
Bought
Sold
Net
Holding
Of company
Worth
Change
Paul David C
Executive Chairman
—
$154.62M (18) scheduled
−$154.62M
60,417
0.0450%
$4.51M
−94.4%
Demski David M
President, CEO
—
$61.74M (16) scheduled
−$61.74M
0
0.0000%
$0.00
−100.0%
Scavilla Daniel T
President, CEO
—
$34.20M (8) scheduled
−$34.20M
0
0.0000%
$0.00
—
Davidar David D
Director
—
$30.21M (22) scheduled
−$30.21M
673,642
0.5017%
$50.24M
−29.8%
Williams Anthony L
President
—
$17.85M (7) scheduled
−$17.85M
0
0.0000%
$0.00
—
Lemaitre Dan
Director
—
$8.75M (5) scheduled
−$8.75M
0
0.0000%
$0.00
—
TOBIN JAMES R
Director
—
$8.67M (11) scheduled
−$8.67M
0
0.0000%
$0.00
—
Huller Kelly
EVP, GC, Corporate Secretary
—
$8.05M (21) scheduled
−$8.05M
0
0.0000%
$0.00
−100.0%
Pfeil Keith W
President, CEO
—
$6.21M (9) scheduled
−$6.21M
0
0.0000%
$0.00
—
ZARRILLI STEPHEN T
Director
—
$4.28M (2) scheduled
−$4.28M
0
0.0000%
$0.00
—
RHOADS ANN D
Director
—
$3.05M (5) scheduled
−$3.05M
40,384
0.0301%
$3.01M
—
Murphy A Brett
EVP, International Sales
—
$2.76M (3)
−$2.76M
35,217
0.0262%
$2.63M
−69.7%
Kline Kyle
Senior Vice President, CFO
—
$2.03M (2) scheduled
−$2.03M
0
0.0000%
$0.00
—
Schwartz Eric
Senior VP and General Counsel
—
$1.74M (3) scheduled
−$1.74M
0
0.0000%
$0.00
—
Payne Steven
Chief Accounting Officer
—
$1.45M (3)
−$1.45M
0
0.0000%
$0.00
−100.0%
Norwalk Leslie V
Director
—
$1.18M (4) scheduled
−$1.18M
10,419
0.0078%
$777.08K
—
Douglas Robert Andrew
Director
$99.82K (3)
—
+$99.82K
2,005
0.0015%
$149.54K
—
Wolterman Dan
Director
—
—
—
24,025
0.0179%
$1.79M
—
DeFord John A
Director
—
—
—
15,578
0.0116%
$1.16M
—

Individual transactions

15
Insider
Date
Role
Action
Shares
Price
Amount
Norwalk Leslie V
8 Jan 2026
Director
Sold on a plan
2,000
$101.10
$202.20K
Norwalk Leslie V
12 Dec 2025
Director
Sold on a plan
4,000
$88.85
$355.40K
RHOADS ANN D
10 Nov 2025
Director
Sold on a plan
2,000
$85.00
$170.00K
RHOADS ANN D
7 Nov 2025
Director
Sold on a plan
8,000
$81.00
$648.00K
RHOADS ANN D
15 Sep 2025
Director
Sold on a plan
10,000
$58.46
$584.60K
RHOADS ANN D
28 Feb 2025
Director
Sold on a plan
7,500
$78.68
$590.10K
Davidar David D
22 Nov 2024
Director
Sold on a plan indirect
6,746
$85.00
$573.43K
Davidar David D
22 Nov 2024
Director
Sold on a plan
6,766
$85.00
$575.14K
Davidar David D
21 Nov 2024
Director
Sold on a plan indirect
13,254
$85.00
$1.13M
Davidar David D
21 Nov 2024
Director
Sold on a plan
13,234
$85.00
$1.12M
Davidar David D
16 Oct 2024
Director
Sold on a plan indirect
20,000
$75.03
$1.50M
Davidar David D
16 Oct 2024
Director
Sold on a plan
30,000
$75.04
$2.25M
Norwalk Leslie V
11 Jul 2024
Director
Sold on a plan
1,000
$70.00
$70.00K
Davidar David D
8 May 2024
Director
Sold on a plan
20,000
$65.00
$1.30M
Norwalk Leslie V
15 Mar 2024
Director
Sold on a plan
10,590
$51.99
$550.57K
Show all 149 transactions →

What was left out

Form 4 filings counted 233
Amendments (4/A) skipped 4
Filings about a different issuer 0
Unreadable filings 0
Joint filings 0
Sales on a Rule 10b5-1 plan 15
Sales straight out of an exercise 108
Sales at will 16
Transactions with no price 0
Shares from compensation/vesting 4,606,089
Sales filed before the plan box existed 16
History held since 1 Feb 2017